PMC3409118_01
Primary nodule at the left costal arch, June 2010.
pntd.0001747.g001.jpg
PMC3409118_01_pntd.0001747.g001.jpg
pntd-0001747-g001
Scar of the primary nodule at the left costal arch, September 2010.
pntd.0001747.g002.jpg
PMC3409118_01_pntd.0001747.g002.jpg
pntd-0001747-g002
IS2404 PCR from a 3-mm punch biopsy sample (Table 1) at the Department of Infectious Diseases and Tropical Medicine (DITM), Munich, and a full course of rifampicin (300 mg/d) and streptomycin (0.5 g/d) was administered for eight weeks at the peripheral health post ("Unite de Soins Peripherique", USP). The patient was fully compliant throughout the entire period of treatment and no complications were reported. In September 2010, the lesion was completely healed under scarification (Figure 2) and the patient was considered cured.
Secondary ulcerated nodule at the back of the right thigh, July 2011.
pntd.0001747.g003.jpg
PMC3409118_01_pntd.0001747.g003.jpg
pntd-0001747-g003
In July 2011, the boy (in the meantime nine-year-old) presented again with a secondary nodule (diameter: 30 mm) at the back of the right thigh (Figure 3) at CHR Maritime one week after its emergence.
Scar of secondary nodule at the back of the right thigh, September 2011.
pntd.0001747.g004.jpg
PMC3409118_01_pntd.0001747.g004.jpg
pntd-0001747-g004
The lesion healed completely (Figure 4) five weeks after onset of disease.